Intracerebroventricular injection of ouabain causes mania-like behavior in mice through D2 receptor activationAlexander V. Lopachev, Raul R. Gainetdinov|Scientific Reports|2019Cited by 35
Ouabain-Induced Gene Expression Changes in Human iPSC-Derived Neuron Culture Expressing Dopamine and cAMP-Regulated Phosphoprotein 32 and GABA ReceptorsAlexander V. Lopachev, Raul R. Gainetdinov|Brain Sciences|2021Cited by 2
Long-term Intracerebroventricular Administration of Ouabain Causes Motor Impairments in C57Bl/6 MiceYulia A. Timoshina, Alexander V. Lopachev|Annals of Clinical and Experimental Neurology|2024Cited by 1
From Stress to Neurodegeneration: A New Look at the Pathogenesis of Parkinson’s DiseaseRogneda B. Kazanskaya, Alexander V. Lopachev, Vassiliy Tsytsarev et al.|Biomedicines|2026Cited by 0
Chronic Administration of Marinobufagenin in Mice Causes Hyperlocomotion and Decrease in Anxiety by Altering Monoamine Turnover Unaccompanied by Motor Deficits or Oxidative StressRogneda B. Kazanskaya, Alexander V. Lopachev, Olga I. Kulikova et al.|International Journal of Molecular Sciences|2026Cited by 0